Longenesis
a platform of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those in need worldwide
Inactive project This project is no longer active; its website is not linked.
a Medical Big-data platform. It gives patients ownership of their own medical data. (Project seems inactive or has been aborted)
This project is marked as inactive in our database. Information may be outdated.
Patients decide how anonymized they want their data to be, but can opt to let medical scientists discover new cures for the ailments that are of interest to you by treating the MediChain data as 'big data'.
MediChain costs patients and doctors nothing. Patients can choose to sell their data to pharmaceutical companies in an anonymised form to help bring cures to market for the problems that they themselves suffer from.
We are starting from the Medrec system developed at MIT and with key team member heading setting that up as our MVP. We have plans for technology that will increase transaction speed up to 14400x faster than the current state of the art technologies.
This is a market with over 2 000 000 000 Potential Clients. MediChain solves problems multiple $ billion markets including one (drug design) with a market value of $150Bn+ pa.
a platform of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those in need worldwide
a web3 platform that enables equitable tracing over #Biosamples & #Biodata (DNA, RNA, Microbiome) using NFTs.
a platform which digitizes the stakeholders in the drug distribution chain.
a decentralised biotech protocol porting intellectual property into web3 and launching biotech DAOs
an Healthcare data analytics & AI company, building the world’s largest genetic & precision medicine data marketplace.
a start-up using distributed ledger technology and AI to save lives and create efficiencies in the healthcare sector